Liver Cancer
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jun 21, 2007; 13(23): 3164-3170
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3164
Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: Randomized placebo-controlled trial
D Dimitroulopoulos, D Xinopoulos, K Tsamakidis, A Zisimopoulos, E Andriotis, D Panagiotakos, A Fotopoulou, C Chrysohoou, A Bazinis, D Daskalopoulou, E Paraskevas
D Dimitroulopoulos, D Xinopoulos, K Tsamakidis, A Zisimopoulos, E Andriotis, A Fotopoulou, D Daskalopoulou, E Paraskevas, Liver Cancer Unit, “Agios Savvas” Cancer Hospital, Athens, Greece
D Panagiotakos, Laboratory of Biostatistics, Department of Nursing, University of Athens, Greece
C Chrysohoou, Hippokration Hospital, University of Athens, Greece
A Bazinis, Psychiatric Department, “Agios Savvas” Cancer Hospital, Athens, Greece
Author contributions: All authors contributed equally to the work.
Correspondence to: Dimitris Dimitroulopoulos, Liver Cancer Unit, “Agios Savvas” Cancer Hospital, 35 Parnassou str., GR-152 34 Halandri-Athens, Greece. dimdim@otenet.gr
Telephone: +30-210-6892460 Fax: +30-210-6420146
Received: February 11, 2007
Revised: March 10, 2007
Accepted: March 15, 2007
Published online: June 21, 2007
Core Tip